ConductScience.org, home

Paper36947282

Joint longitudinal model-based meta-analysis of FEV1 and exacerbation rate in randomized COPD trials.

Llanos-Paez C and 5 others. J Pharmacokinet Pharmacodyn, 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Joint longitudinal model-based meta-analysis of FEV1 and exacerbation rate in randomized COPD trials. Papers, record 36947282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36947282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Joint longitudinal model-based meta-analysis of FEV1 and exacerbation rate in randomized COPD trials.
PubMed
Journal
J Pharmacokinet Pharmacodyn
PubMed
Year
2023
PubMed
Publication types
Meta-Analysis, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2023-08-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Llanos-Paez CCarolina
2Ambery CClaire
3Yang SShuying
4Beerahee MMisba
5Plan ELElodie L
6Karlsson MOMats O

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pulmonary Disease, Chronic ObstructiveMajor topic
Humans
Forced Expiratory Volume

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127103795A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.Int J Chron Obstruct Pulmon Dis2016https://conductscience.org/library/papers/27103795PubMed
229668352Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.N Engl J Med2018https://conductscience.org/library/papers/29668352PubMed
330993679Model-Based Meta-Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence.Clin Pharmacol Ther2019https://conductscience.org/library/papers/30993679PubMed
427663386Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.Respir Res2016https://conductscience.org/library/papers/27663386PubMed
528480503Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis.Clin Pharmacol Ther2017https://conductscience.org/library/papers/28480503PubMed
627730198A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD.ERJ Open Res2016https://conductscience.org/library/papers/27730198PubMed
721518459Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches.Respir Res2011https://conductscience.org/library/papers/21518459PubMed
820843247Susceptibility to exacerbation in chronic obstructive pulmonary disease.N Engl J Med2010https://conductscience.org/library/papers/20843247PubMed
921991892Changes in forced expiratory volume in 1 second over time in COPD.N Engl J Med2011https://conductscience.org/library/papers/21991892PubMed
1027884052Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.CPT Pharmacometrics Syst Pharmacol2017https://conductscience.org/library/papers/27884052PubMed
1128993871
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Lung2017https://conductscience.org/library/papers/28993871PubMed
1218836213A 4-year trial of tiotropium in chronic obstructive pulmonary disease.N Engl J Med2008https://conductscience.org/library/papers/18836213PubMed
1328375647FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med2017https://conductscience.org/library/papers/28375647PubMed
1435174432Applications of Model-Based Meta-Analysis in Drug Development.Pharm Res2022https://conductscience.org/library/papers/35174432PubMed
1526517752Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.J Clin Pharmacol2016https://conductscience.org/library/papers/26517752PubMed
1627299940Clinical Trial Simulations From a Model-Based Meta-Analysis of Studies in Patients With Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy.CPT Pharmacometrics Syst Pharmacol2016https://conductscience.org/library/papers/27299940PubMed
1710195646Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM.Comput Methods Programs Biomed1999https://conductscience.org/library/papers/10195646PubMed
1823836189Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose.CPT Pharmacometrics Syst Pharmacol2013https://conductscience.org/library/papers/23836189PubMed
1930846476Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.Eur Respir J2019https://conductscience.org/library/papers/30846476PubMed
2029094315Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study.Adv Ther2017https://conductscience.org/library/papers/29094315PubMed

See all 32 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
41023527Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach.Dermatol Ther (Heidelb)2025https://conductscience.org/library/papers/41023527PubMed
40536286A Combined Model-Based Meta-Analysis of Aggregated and Individual FEV1 Data From Randomized COPD Trials.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/40536286PubMed
40442865Examining the Reliability of Model-Based Meta-Analysis (MBMA) Outcomes: A Simulation Study.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/40442865PubMed
39164859Predicting progression-free survival from measurable residual disease in chronic lymphocytic leukemia.Clin Transl Sci2024https://conductscience.org/library/papers/39164859PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CALML3810PubTator's text mininghttps://conductscience.org/library/genes/810NCBI Gene
MOK5891PubTator's text mininghttps://conductscience.org/library/genes/5891NCBI Gene
NR5A12516PubTator's text mininghttps://conductscience.org/library/genes/2516NCBI Gene
PDE4A5141PubTator's text mininghttps://conductscience.org/library/genes/5141NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36947282

GET https://conductscience.org/api/papers/v1/36947282/references?page=2